As of Feb 09
| -0.0554 / -17.20%|
The 1 analysts offering 12-month price forecasts for Alexza Pharmaceuticals Inc have a median target of 1.25, with a high estimate of 1.25 and a low estimate of 1.25. The median estimate represents a +368.87% increase from the last price of 0.27.
The current consensus among 1 polled investment analysts is to Hold stock in Alexza Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.